| Dataset | BreastCancer Custom__BreastCancer_custom-females- |
| Phenotype | NoPhenotypeAvailable |
| Upregulated in class | na_pos |
| GeneSet | CL22980, NEUREXINS AND NEUROLIGINS, AND REGULATION OF PRESYNAPSE ASSEMBLY |
| Enrichment Score (ES) | 0.5365688 |
| Normalized Enrichment Score (NES) | 1.228761 |
| Nominal p-value | 0.087 |
| FDR q-value | 0.76274025 |
| FWER p-Value | 0.986 |

| SYMBOL | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
|---|---|---|---|---|---|
| 1 | CDH9 | 324 | 1.775 | 0.1161 | Yes |
| 2 | DLGAP3 | 376 | 1.682 | 0.2404 | Yes |
| 3 | GRM5 | 951 | 1.222 | 0.3008 | Yes |
| 4 | NRXN1 | 2121 | 0.836 | 0.2989 | Yes |
| 5 | CLSTN3 | 2126 | 0.835 | 0.3618 | Yes |
| 6 | SLITRK5 | 2662 | 0.732 | 0.3873 | Yes |
| 7 | FBXO40 | 2696 | 0.725 | 0.4403 | Yes |
| 8 | GRID2 | 2889 | 0.699 | 0.4824 | Yes |
| 9 | CNTN4 | 3421 | 0.625 | 0.5001 | Yes |
| 10 | GRM1 | 3587 | 0.605 | 0.5366 | Yes |
| 11 | NRXN2 | 6606 | 0.356 | 0.3956 | No |
| 12 | NLGN2 | 7304 | 0.318 | 0.3809 | No |
| 13 | SHANK1 | 7556 | 0.306 | 0.3900 | No |
| 14 | SYNGAP1 | 8861 | 0.251 | 0.3364 | No |
| 15 | DLG4 | 9303 | 0.235 | 0.3296 | No |
| 16 | NLGN1 | 10947 | 0.182 | 0.2520 | No |
| 17 | LRRTM1 | 11398 | 0.169 | 0.2397 | No |
| 18 | SHANK3 | 11405 | 0.169 | 0.2521 | No |
| 19 | DLGAP4 | 11465 | 0.167 | 0.2614 | No |
| 20 | SHANK2 | 11524 | 0.165 | 0.2707 | No |
| 21 | NRXN3 | 11785 | 0.158 | 0.2681 | No |
| 22 | TJAP1 | 12455 | 0.140 | 0.2415 | No |
| 23 | NLGN3 | 13893 | 0.110 | 0.1698 | No |
| 24 | DLG3 | 14184 | 0.104 | 0.1616 | No |
| 25 | MDGA1 | 14267 | 0.102 | 0.1647 | No |
| 26 | PTCHD1 | 14346 | 0.101 | 0.1680 | No |
| 27 | CBLN1 | 14624 | 0.095 | 0.1597 | No |
| 28 | DLGAP1 | 14749 | 0.093 | 0.1598 | No |
| 29 | NLGN4X | 15190 | 0.084 | 0.1417 | No |
| 30 | CBLN4 | 15317 | 0.081 | 0.1408 | No |
| 31 | CBLN2 | 15418 | 0.079 | 0.1413 | No |
| 32 | HOMER3 | 16833 | 0.036 | 0.0653 | No |
| 33 | HOMER2 | 17072 | -0.000 | 0.0521 | No |
| 34 | DLG2 | 17452 | -0.000 | 0.0310 | No |
